moxifloxacin has been researched along with pyruvic acid in 1 studies
| Studies (moxifloxacin) | Trials (moxifloxacin) | Recent Studies (post-2010) (moxifloxacin) | Studies (pyruvic acid) | Trials (pyruvic acid) | Recent Studies (post-2010) (pyruvic acid) |
|---|---|---|---|---|---|
| 3,157 | 552 | 1,690 | 8,310 | 169 | 2,501 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arnanz, C; de la Campa, AG; Ferrándiz, MJ; Martín-Galiano, AJ; Zimmerman, T | 1 |
1 other study(ies) available for moxifloxacin and pyruvic acid
| Article | Year |
|---|---|
Reactive Oxygen Species Contribute to the Bactericidal Effects of the Fluoroquinolone Moxifloxacin in Streptococcus pneumoniae.
Topics: Acetyl-CoA Carboxylase; Acetyltransferases; Anti-Bacterial Agents; Bacterial Proteins; DNA Topoisomerase IV; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Fructosephosphates; Gene Deletion; Gene Expression Profiling; Gene Expression Regulation, Bacterial; Gene Ontology; Glycolysis; Hydrogen Peroxide; Iron; Levofloxacin; Microbial Sensitivity Tests; Molecular Sequence Annotation; Moxifloxacin; Oxidative Stress; Pyruvate Oxidase; Pyruvic Acid; Streptococcus pneumoniae; Transcription, Genetic | 2016 |